| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 5.147 | 750 | 6.206 | 18.481 | 8.894 |
| Total Income - EUR | - | - | - | - | - | 5.147 | 750 | 6.206 | 18.481 | 8.894 |
| Total Expenses - EUR | - | - | - | - | - | 0 | 68 | 345 | 1.470 | 1.549 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 5.147 | 682 | 5.862 | 17.011 | 7.345 |
| Net Profit/Loss - EUR | - | - | - | - | - | 4.993 | 672 | 5.835 | 14.508 | 6.141 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 1 | 0 |
Check the financial reports for the company - Advlas Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 550 |
| Current Assets | - | - | - | - | - | 5.147 | 5.554 | 12.249 | 29.197 | 6.714 |
| Inventories | - | - | - | - | - | 0 | 0 | 243 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 0 | 12.007 | 27.680 | 4.934 |
| Cash | - | - | - | - | - | 5.147 | 5.554 | 0 | 1.517 | 1.780 |
| Shareholders Funds | - | - | - | - | - | 4.993 | 5.554 | 11.485 | 25.903 | 6.190 |
| Social Capital | - | - | - | - | - | 0 | 0 | 0 | 40 | 40 |
| Debts | - | - | - | - | - | 154 | 0 | 765 | 3.293 | 1.074 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Advlas Med S.r.l.